Latest news
Ziphius Announces Appointment of Damien Dessis as Chief Business Officer (CBO)
October 10, 2024
Ziphius, a leading biotechnology company developing self-amplifying RNA (saRNA) vaccines and therapeutics, today announced the appointment of Damien Dessis as Chief Business Officer. In this role, Mr. Dessis will be responsible for overseeing the Company’s business development and overall corporate strategy.